Delivery Order SPE2DB22D3010-SPE2DB24FP3EL

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,018.59 firm-fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count bottles. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,467.63 firm-fixed-price delivery order is for the supply of 90 tablets of the medication Valsartan-HCTZ 80-12.5 mg. The contract has an ultimate completion date of October 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.26 firm fixed-price delivery order is for 4566737140 - VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, with an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.03 firm-fixed-price delivery order is for the supply of 4567610035 - VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a performance period ending on March 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,133.66 firm fixed-price contract is for the supply of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication, to support military healthcare programs. The contract has a completion date of June 4, 2024 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,368.78 firm fixed-price delivery order is for VALSARTAN-HCTZ 160-12.5 MG TAB 90S, with a completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,422.27 firm-fixed-price delivery order is for the supply of 4,568,185,962 units of the medication Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,462.85 firm fixed-price delivery order is for the supply of 4,564,404,281 units of the medication Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of April 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,139.83 Firm Fixed Price delivery order is for the supply of VALSARTAN-HCTZ 160-25 MG TAB 90S, a prescription medication used to treat high blood pressure. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,408.14, is a Delivery Order for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024, and is a Firm Fixed Price contract. This award is not associated with a set-aside program. In addition to this...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP3EL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,786.63 firm fixed-price delivery order is for the supply of 4565682065 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a prescription medication. The award has an ultimate completion date of September 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation.

Generated 12/4/24, 9:36 AM